This is the point where you need to be honest with yourself
Breastfeeding is not recommended during trial participation
Antioxidant Substrate Availability GLP-1RAs demonstrate anti-inflammatory [80] and antioxidant-associated effects [81] across both preclinical and clinical studies, although findings are not entirely consistent [82]
Stable Gastric Pentadecapeptide BPC 157 in Trials for Inflammatory Bowel Disease (PL-10, PLD-116, PL 14736, Pliva) Current Pharmaceutical Design Comprehensive review of BPC 157 clinical development for inflammatory bowel disease including ulcerative colitis trials, demonstrating mucosal healing and anti-inflammatory effects across multiple organ systems
Daily oral medication provides limited suppression that wears off between doses (especially if you miss a day or dont follow strict timing rules)
Its long half-life, around 7 days, is due to mechanisms that prevent rapid breakdown and allow for convenient once-weekly dosing